Introduction
and 11.3 ng/ml measured by IMx (Abbott).
Ten weeks after initiation of rescue therapy, the Tacrolimus ( FK 506 ) has been demonstrated to be a patient developed polydipsia, nausea, headache, potent immunosuppressive agent in organ transplanta-blurred vision, and weakness. A urine test revealed tion [1] . The drug is now available as rescue therapy glucosuria, and the patient was admitted to hospital. for steroid resistant rejection in organ transplantation. There was no ketonuria. On examination, the patient Diabetes mellitus as a complication of the use of showed a 5% weight loss, a dry mouth, and a mild Tacrolimus has been reported in adult [2] and paediatric tremor. A blood sample showed a serum glucose of [3 ] renal transplant patients. The pathogenesis of dia-41.2 mmol/l, and a C-peptide of 11.4 ng/ml. A second betes mellitus secondary to Tacrolimus is not well C-peptide measurement was 9.2 ng/ml while still on understood, and there is controversy as to whether a insulin injections, suggesting increased endogenous correlation of this complication to Tacrolimus serum insulin production (normal value after 12 h of fasting levels [4] does exist. We report on a case which docu-<3.5 ng/ml ). Unfortunately, no information is ments a correlation between a high Tacrolimus trough available on insulin concentrations available prior to level and onset of insulin requiring diabetes mellitus.
commencing insulin infusion. Autoantibodies against insulin and islet cells were negative. IGF-1 was 429.1 ng/ml, and 1 week later declined to 347.8 ng/ml
Case report (normal range 240-696 ng/ml for 12-17 year-old girls). Serum creatinine had increased from 190 to 256 mmol/l. A now 13-year-old girl with end-stage renal failure and Acidosis was absent. One week before admission, chronic persistant hepatitis C was successfully trans-Tacrolimus trough level had been >15 ng/ml, and on planted with a maternal graft in May 1989. The admission Tacrolimus trough level was at 36.5 ng/ml underlying renal disease was histologically proven xan-(therapeutic range: 6-11 ng/ml ). thogranulomatous pyelonephritis. There was no family
The patient was treated with intravenous and subhistory of diabetes mellitus. Immunosuppression after cutaneous insulin injections. Blood glucose level contransplantation consisted of ATG, cyclosporine (CsA) trol was difficult. Despite insulin doses of 75 units per and steroids. The maternal graft had one match each day (i.e. 1.8 units per kg), it was not possible to achieve on HLA A, B and D, and there was rhesus incompatib-normoglycaemia. It is noteworthy that the patient was ility. Two rejection episodes were treated with steroids, remarkably well with blood glucose levels of up to and serum creatinine subsequently was 130 mmol/l. 40 mmol/l. An acute rejection episode was diagnosed in January Tacrolimus was discontinued, and Tacrolimus levels 1996 with a rise of serum creatinine to 230 mmol/l, were 24 ng/ml after 12 h, 10.6 ng/ml after 24 h, and doubling of kidney volume and rise of resistance index 7.7 ng/ml after 48 h, respectively. Serum creatinine by more than 10%. There was no response to a 6-day decreased to 208 mmol/l. Tacrolimus was discontinued and the patient was switched back to CsA. One day Correspondence and offprint requests to: Guido Filler, Department later the patient was normoglycaemic receiving 67 units insulin injections were needed. Two weeks after onset of diabetes mellitus C-peptide was still elevated at 9.6 ng/ml, and insulin was also elevated at 50.0 mU/ml. HbA1c was 5.4% 2 months before the onset of diabetes, 9.6% 1 week after onset of diabetes, 7.5% 2 weeks later, and 5.1% at the latest follow-up 3 months after the event. An intravenous glucose tolerance test was performed 4 weeks after onset of diabetes and showed a normal k-value of 1.63. Early insulin secretion was 91.3 mU/ml at 1 min and 84.6 mU/ml at 3 min after intravenous glucose load. The sum of the first and third minute insulin values was normal at 175.9 mU/ml. The 10∞-60∞ integral in this patient was 2113 mU/ml/min (normal second phase insulin production ranges from 400 to 2520 mU/ml/min in pubertal adolescents). Results of the glucose tolerance test are Fig. 2 . Intravenous glucose tolerance test 9 weeks after onset of summarized in Figure 1 . C-peptide was high prior to diabetes: k-value normal at 1.87, insulin sum at 1 and 3∞ 145.4 mU/ml. the test and increased to a maximum of 15.9 ng/ml. A second glucose tolerance test was performed 9 weeks after the onset of diabetes, and this time C-peptide an incidence of 2% diabetes mellitus has been reported [6 ] . In a recent communication, 3/19 paediatric renal was normal for the degree of renal failure at 4.85 ng/ml. Normal values of C-peptide in our laboratory transplant patients treated with Tacrolimus developed diabetes mellitus. All of them had a positive family are 0.78±0.54 ng/ml in normal children (n=5), 0.96±0.48 ng/ml in children with Turner syndrome history of non-insulin dependent diabetes mellitus [3 ] .
Few data are available on insulin secretion and (n=11), 2.58±1.62 ng/ml in children with a reduced GFR and a serum creatinine below 100 mmol/l (n=6), C-peptide in Tacrolimus induced diabetes. Three children developing diabetes mellitus on Tacrolimus 3.12±1.47 ng/ml in children with a serum creatinine between 100 and 200 mmol/l (n=6), 4.26±2.67 ng/ml after liver transplantation were reported with elevated C-peptide [7 ] . It was argued that the absence of in children with a serum creatinine above 200 mmol/l (unpublished data). The second glucose tolerance test ketonuria in the face of significant hyperglycaemia supports the hypothesis that there is no insulin defiwas completely normal (figure 2 ).
ciency involved in the development of Tacrolimus induced diabetes mellitus. Our patient also showed Discussion absence of ketonuria. Even in non-diabetic liver transplant recipients on Tacrolimus, C-peptide concentrations were found to be significantly increased when Diabetes mellitus is an important complication after compared to healthy controls. C-peptide concentraorgan transplantation. Steroids and other immunotions were also increased in liver transplant recipients suppressive agents have been identified as major risk on cyclosporin based immunosuppression. C-peptide factors [4 ] . Despite the use of low dose steroids, response in glucose tolerance tests was increased in Tacrolimus has been associated with the onset of patients on Tacrolimus compared to patients on CSA, diabetes mellitus in one of eight paediatric renal transand the proportion of patients with impaired glucose plant recipients [5] . In paediatric liver transplantation, tolerance was greater in the Tacrolimus treated group. C-peptide can be increased after renal transplantation because of renal insufficiency. In fact, graft function in our patient was impaired. For comparison, we have obtained C-peptide values from children with varying degree of renal insufficiency without renal transplantation. It is noteworthy, that the patient had an increased basal C-peptide 4 weeks after onset of diabetes if compared to the degree of renal insufficiency. Nine weeks after transplantation C-peptide was within the range of children with comparable renal insufficiency. The data demonstrate that glucose tolerance was impaired in our patient on high Tacrolimus trough levels. The increased C-peptide blood levels suggests that there was increased endogenous insulin production. Glucose tolerance impairment ceased immediately following cessation of Tacrolimus, however, increased blood C-peptide were found up to 4 weeks after onset 
